RxDoctor Payments Data

Jerika Kirwan

Optometrist · Wagner, SDNPI 1174906705

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,000 of the $6,397 with a category attached, or 62.5%. Alcon accounts for 68.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $4,431 and has fallen 94.5% since, to $243 in 2025. Among optometrist clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,397in general payments, 2019–2025

Across 56 payments — averaging $114.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$4K
  • Bausch & Lomb Americas Inc.$1K
  • Johnson & Johnson Vision Care, Inc.$821
  • Plexus Optix, Inc.$144
  • Carl Zeiss Meditec AG$19

What the payments were for

  • Speaking & faculty fees$4,00063%
  • Food & beverage$2,37837%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,397 in reported general payments places this provider in the 95th percentile of 206 optometrist providers in South Dakota.

See all optometrist providers in South Dakota

Medicare billing

Part B allowed, 2024
$81,162
Medicare patients
410
Services billed
943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine17$7,788
LumiganBimatoprost13$3,263
Latanoprost128$1,828
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol17$1,349
Fluorometholone11$650
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat14$468
Timolol Maleate22$312
ErythromycinErythromycin Base12$124

Paid to pharmacies, not to this prescriber.

Other optometrist in Wagner

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →